WeightWatchers gets into prescription weight loss business

In a clinical trial, adults who used Wegovy lost about 15% of their initial body weight, while teens lost slightly more. For best results, the drugs should be combined with diet and exercise, experts say. Trulicity is a different drug, dulaglutide, used to treat diabetes in adults and children ages 10 and older. It’s not approved to treat obesity.

Both Ozempic and Wegovy can cause possible side effects, the company reports. They include possible thyroid cancer, pancreatitis, kidney and gallbladder problems. The most common side effects are nausea, vomiting, diarrhea, stomach pain and constipation. The estimated annual medical cost of obesity in the U.S. was almost $173 billion in 2019 dollars, according to the CDC. Annual medical costs for adults who had obesity were $1,861 higher than medical costs for people with healthy weight.

Lasser said that WW's business has been disrupted over the last several years and is now trying to take big steps to course correct.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WeightWatchers to buy Sequence telehealth, enter obesity drug prescription businessWW International Inc, known as WeightWatchers, said on Monday it is acquiring subscription telehealth platform Sequence, moving the weight-loss program operator into the obesity drug prescription business. WeighWatchers said it expects its $132 million acquisition in cash and stock will complement its nutrition and behavior-change program for weight loss at a time when obesity drugs are seen as one of the biggest markets for drugmakers.
Source: YahooNews - 🏆 380. / 59 Read more »

WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors. Isn't moving into the Ozempic market an implicit admission that their product doesn't work. 'You can totally lose weight and keep it off with our points system... but on second thought, here's some drugs.' 황금으로 만든 골든 이글이 필요해
Source: WSJhealth - 🏆 413. / 53 Read more »

WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Source: WSJhealth - 🏆 413. / 53 Read more »